TMED

$29.46

Fund Essentials - as of Aug 29, 2025

Net Assets
-
Expense Ratio
0.44%
Dividend Yield (Current)
-
Holdings
100
Inception Date
Jun 11, 2025
Fund Family
T.Rowe Price
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
NA

Performance

YTD+0.00%
1 Year+0.19%
3 Year+0.19%
5 Year+0.19%
10 Year+0.19%

Asset Allocation

Stocks: 99.55%
Cash: 0.45%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.13.71%
UNHUnitedHealth Group Incorporated7.60%
ABBVAbbvie Inc.6.45%
ABTAbbott Laboratories4.69%
DHRDanaher Corp.4.07%
Top 10 Concentration: 52.24%Report Date: Aug 29, 2025

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+0.56%
YTD
+18.67%
1 Year
+18.67%
3 Year
+18.67%

Top 10 Holdings (52.2% of portfolio)

#TickerNameSectorWeight
1LLYEli Lilly & Co.Health Care13.71%
2UNHUnitedHealth Group IncorporatedHealth Care7.60%
3ABBVAbbvie Inc.Health Care6.45%
4ABTAbbott LaboratoriesHealth Care4.69%
5DHRDanaher Corp.Health Care4.07%
6BDXBecton Dickinson And Co.Health Care3.91%
7ISRGIntuitive Surgical Inc.Health Care3.89%
8GILDGilead Sciences IncHealth Care3.43%
9ELANElanco Animal Health, Inc CvrHealth Care2.49%
10REGNRegeneron Pharmaceuticals, Inc.Health Care2.00%